USPTO serial 78133926
SUREHEALTH
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- FOSDICK, GEOFFREY A
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SUREHEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matt C. Deering
MATT C DEERING MEYER CAPEL, A PROFESSIONAL CORPORATION306 W CHURCH STCHAMPAIGN, IL 61820UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 029 | pure and hydrogenated vegetable oils | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 12, 2003 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Jun 12, 2003 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 12, 2003 | PAPER RECEIVED | — | |
| Jan 21, 2003 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Dec 17, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 27, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 7, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 24, 2002 | DOCK | ASSIGNED TO EXAMINER | — |